Price Chart

Profile

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
URL https://www.catalystpharma.com
Investor Relations URL https://ir.catalystpharma.com/
HQ State/Province Florida
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 28, 2024
Last Earnings Release Nov. 08, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
URL https://www.catalystpharma.com
Investor Relations URL https://ir.catalystpharma.com/
HQ State/Province Florida
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 28, 2024
Last Earnings Release Nov. 08, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A